PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
08-Mar-2024 US FDA grants Orphan Drug Designation for iOnctura’s first-in-class autotaxin cancer therapy iOnctura
08-Mar-2024 GC Aesthetics celebrates the voices of its inspirational females ahead of International Women’s Day GC Aesthetics
08-Mar-2024 CD BioSciences Unveiled WMicroTrackers, Powered by Non-invasive Tracking Technology CD BioSciences
07-Mar-2024 RDS SECURES CE MARK FOR MULTISENSE® REMOTE PATIENT MONITORING SOLUTION RDS
07-Mar-2024 InnoScot Health aims to inspire inclusive, innovative healthcare on International Women’s Day InnoScot Health
07-Mar-2024 Public concern about the NHS soars as delays accessing A&E and GP services rise London Medical Laboratory
06-Mar-2024 Semantic Data 2024: Taxonomy, Ontology and, Knowledge Graphs - First Speakers Announced Henry Stewart Events
06-Mar-2024 Zenas BioPharma Appoints Patricia Allen to its Board of Directors Zenas BioPharma
06-Mar-2024 Almac Group Expands Commercial Manufacturing and Packaging as well as Peptide Production Capacity at Headquarters with Two New Purpose-Built Facilities Almac Group
06-Mar-2024 Women in Life Science Denmark (WiLD) to host network meeting in collaboration with DANISH BIO to promote equity in the Danish life science industry Women in Life Science Denmark (WiLD)
06-Mar-2024 FDA Clears Beckman Coulter Life Sciences DxFLEX Flow Cytometer Beckman Coulter Life Sciences
06-Mar-2024 Jemperli▼ (dostarlimab) becomes the first immunotherapy treatment to receive NICE recommendation for use, in line with its license, in eligible endometrial cancer patients in first line setting GSK
05-Mar-2024 ADARE PHARMA SOLUTIONS TO EXPAND PACKAGING & WAREHOUSING CAPABILITIES IN EUROPE Adare Pharma Solutions
05-Mar-2024 The York Health Economic Consortium will undertake the first UK health economic analysis of Ondine’s Steriwave light-activated antimicrobial to reduce Surgical Site Infections York Health Economics Consortium (YHEC)
05-Mar-2024 Ariceum Therapeutics announces opening of new state-of-the-art laboratory in Berlin providing infrastructure for radiopharmaceutical development activities Ariceum Therapeutics
05-Mar-2024 Transgene, NEC and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050 Transgene
05-Mar-2024 Lundbeck presents encouraging results from the Lu AF82422 trial for Multiple System Atrophy at the international AD/PD 2024 conference on neurodegenerative disorders Lundbeck A/S
05-Mar-2024 ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses ViiV Healthcare
05-Mar-2024 BellaSeno’s 3D-printed Resorbable Scaffold Successfully Used in Critical-Size Large Segmental Radius Bone Defect at Hannover Medical School BellaSeno GmbH
04-Mar-2024 CSL Behring Signs First Commercial Agreement in Austria to Fund Haemophilia B Gene Therapy HEMGENIX® CSL Behring